Because of its potent anti-inflammatory action, resveratrol is thought to slow the progression of PD (Cirano et al., 2021), and some research has highlighted its important role in patients with type 2 diabetes and associated periodontitis (Zare Javid et al., 2017; Javid et al., 2019), both in the restriction of serum IL6 levels and its ability to reduce glycemia (Huang et al., 2020). Here, IL6 is linked to periodontitis.